Kaposi’s Sarcoma
The interest in Kaposi`s sarcoma (KS) was renewed with the HIV pandemic, once the former is an AIDS defining malignancy. Although the introduction of protease inhibitors has reduced the incidence of KS, the disease is still the most common cancer affecting AIDS patients. Many questions regarding the...
| Autores: | , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2007 |
| País: | Brasil |
| Institución: | Universidade Federal de Juiz de Fora (UFJF) |
| Repositorio: | HU Revista (Online) |
| Idioma: | portugués |
| OAI Identifier: | oai:periodicos.ufjf.br:article/21 |
| Acceso en línea: | https://periodicos.ufjf.br/index.php/hurevista/article/view/21 |
| Access Level: | acceso abierto |
| Palabra clave: | Sarcoma De Kaposi Herpesvirus 8 Humano Síndromes de Imunodeficiência |
| Sumario: | The interest in Kaposi`s sarcoma (KS) was renewed with the HIV pandemic, once the former is an AIDS defining malignancy. Although the introduction of protease inhibitors has reduced the incidence of KS, the disease is still the most common cancer affecting AIDS patients. Many questions regarding the epidemiology, pathogenesis and diagnosis of this malignancy still remain unanswered. The authors undertook a comprehensive review, incorporating recent discoveries chiefly about early diagnosis, cutaneous presentation, and treatment approaches. |
|---|